Login
Contact

Explore

Explore

About
  • People and Partners
  • TRI Building
  • Reconciliation Action Plan
  • Strategic Plan
  • TRI Foundation
  • Careers
Research
  • Collaborate
  • Discovery
  • Translate
  • Engage
  • Research Areas
Clinical
  • Translational Trials
  • Clinical Research Facility
  • TRI at Children’s
Industry
  • TRI Incubator
  • The Precinct
  • Residents
Manufacture
  • New cGMP Facility
Facilities
  • Cleanroom
  • Flow Cytometry
  • Histology
  • Microscopy
  • Proteomics
  • Preclinical Imaging
  • Biological Research
  • Gnotobiotics
  • Human Immune Model
Get Involved
  • Health Consumers
  • SPARQ-ed
Resources
  • News
  • Events
  • Case Studies
  • Grants and Funding
  • Education and Training

+61 7 3443 7000info@tri.edu.au37 Kent Street, Woolloongabba QLD 4102 Australia

Acknowledgement of Country

TRI acknowledges the traditional custodians of the land we are on today, the Turrbal and Jagera people and we recognise their continuing connection to land, waters and community. We pay deep respect to them and their cultures; and to Elders past, present and emerging.

© Translational Research Institute Pty Ltd atf the Translational Research Institute Trust|ABN: 58 155 991 662
Privacy policy|Terms of Use|Contact Us
TRI · Get Involved · Grants and Funding

Grants and Funding

Get InvolvedNewsEventsCase StudiesGrants and FundingEducation and TrainingSPARQ-ed

TRI grants

TRI research grants, which include co-funding from university, government and industry partners, were specifically designed to foster innovative research with the potential to lead to new medical care for Australians.

“Since 2015, the TRI has awarded 40 research grants worth more than $2.8 million. These grants are enormously important because they fill a critical gap in funding research on the cusp of commercialisation.

Our goal is to foster research at this point and stimulate industry and cross-institutional academic collaborations to ensure patients benefit as quickly as possible from medical breakthroughs.”

Professor Scott Bell

Former TRI CEO

Total grants funded

$1,794,995

TRI Grants

TRI Grants
$27,000

TRI Foundation

TRI Foundation
$1,448,829

LINC Grants

LINC Grants

Apply for a grant

The Leading Innovations through New Collaborations (LINC) program provides dedicated funding for new research collaborations.

2024 LINC Grant scheme

Open to early to mid-career researchers based at TRI and early to mid-career clinicians based at either Metro South Health, Children’s Health Queensland, or Mater Research. The scheme offers $50,000 grants, to foster new, translational research collaborations, seed funding research projects with clinical translation potential.

2024 LINC Grant scheme

Open to early to mid-career researchers based at TRI and early to mid-career clinicians based at either Metro South Health, Children’s Health Queensland, or Mater Research. The scheme offers $50,000 grants, to foster new, translational research collaborations, seed funding research projects with clinical translation potential.

2024 Grant awardees

Lea Dousset (UQ-FI)

2024 Microba Life Sciences Microbiome Sequencing Grant
Grant Awarded: $13250

Project title: 
Determining the Role of Adverse Childhood Experiences (ACEs) in Treatment-Resistant

Lea is part of the UQ Dermatology Research Centre based at TRI. The Onco-Derm is a collaborative study, conducted by a multidisciplinary team of clinicians from the Princess Alexandra Hospital and researchers from UQ-FI.  This study will investigate the serious issue of cutaneous immune-related adverse events from particular immune checkpoint inhibitors in the treatment of cancer, assessing the interactions with the skin microbiome.  

Ben Lazarus (MSH)

2024 PARF/TRI Microgrant
Grant Awarded: $3000

Project title: 
Improving early detection of albuminuria in Queensland

Dr Benjamin Lazarus is a kidney specialist partnering with MSH scientist, A/Prof David Vesey on a pilot study to improve the early detection of albuminuria, as an accurate predictor of kidney disease onset in Queensland.

Emily Watson (MSH)

2024 PARF/TRI Microgrant
Grant Awarded: $3000

Project title: 
Determining the Role of Adverse Childhood Experiences (ACEs) in Treatment-Resistant

Dr Emily Wilson, a consultant neurologist based at the Princess Alexandra Hospital, has established a new collaboration with TRI-based researcher Prof Selena Bartlett from QUT to explore the determining roles of adverse childhood experiences (ACEs) in treatment-resistant epilepsy.  This pilot retrospective cohort study will analyse the impact that ACEs may have of epilepsy, to inform and support clinical plans and to improve patient outcomes.

More Grant Stories

Filter by
Human Immune Models
Ironing out IBD: a new grant in the crusade against anaemia of inflammation

In Australia, IBD is a significant health concern affecting an estimated 100,000 people, and cases are on the rise. It encompasses two main conditions: Crohn’s disease and ulcerative colitis, both of which involve chronic inflammation of the gastrointestinal tract. Known as anaemia of inflammation, an estimated 30% of IBD sufferers will experience anaemia from their disease. It is also seen in patients who suffer other inflammatory and autoimmune diseases.

Fellowship
2024 TRI Translation Fellows announced

The Translational Research Institute (TRI) has awarded four Translation Fellowships to mid-career researchers.

TRI Announcement
New LINC Grants aim to tackle unmet medical need

Seven projects have secured funding from TRI through the latest LINC grants, to progress research in the areas of cancer, children’s immunity and blood infection.

Translational Research
TRI announces 2023 translation fellowships

TRI has awarded four Translation Fellowships to early and mid-career researchers. The 12-month Fellowships, valued at $20,000 each, were launched in 2023 as part of TRI’s flagship Translation Pathways program.

Looking for grant application support?

TRI provides grant application support in the form of letters of support or in-kind funding to researchers based at TRI.
Log in to find out more and applyContact us for more information